Li, S., Qin, J., Sun, Q., Zhao, H., Xiong, Y., Wang, Y., Han, Y., Zhang, J., Zhang, W., Shen, M., Yang, F., Ren, B., Zhou, L., Li, R., Hui, Z., Tian, X., Cao, S., Du, W., Yu, W., Liu, L., Zhang, X., Ren, X. (2026). Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma. Scientific Reports. https://doi.org/10.1038/s41598-026-38881-1